Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Goodwill: 2016-2019

Historic Goodwill for Ironwood Pharmaceuticals (IRWD) over the last 4 years, with Dec 2019 value amounting to $785,000.

  • Ironwood Pharmaceuticals' Goodwill changed negligibly% to $785,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $785,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $785,000 for FY2019, which is negligibly% changed negligibly from last year.
  • According to the latest figures from Q4 2019, Ironwood Pharmaceuticals' Goodwill is $785,000, which was down 0.00% from $785,000 recorded in Q3 2019.
  • Ironwood Pharmaceuticals' Goodwill's 5-year high stood at $785,000 during Q4 2016, with a 5-year trough of $649,000 in Q2 2016.
  • Over the past 3 years, Ironwood Pharmaceuticals' median Goodwill value was $785,000 (recorded in 2019), while the average stood at $785,000.
  • Data for Ironwood Pharmaceuticals' Goodwill shows a peak YoY climbed of 20.96% (in 2017) over the last 5 years.
  • Quarterly analysis of 4 years shows Ironwood Pharmaceuticals' Goodwill stood at $785,000 in 2016, then remained steady at $785,000 in 2017, then remained steady at $785,000 in 2018, then remained steady at $785,000 in 2019.
  • Its Goodwill was $785,000 in Q4 2019, compared to $785,000 in Q3 2019 and $785,000 in Q2 2019.